ArticleGut2023

Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma.

Zhewen Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.